Goldman Sachs Maintains Buy on Waters, Raises Price Target to $515
9/21/2026
Impact: 75
Healthcare
Goldman Sachs analyst Evie Koslosky has reaffirmed a Buy rating on Waters Corporation (NYSE: WAT) and increased the price target from $465 to $515. This adjustment reflects a positive outlook for the company's performance in the market.
AI summary, not financial advice
Share: